Literature DB >> 15789211

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography.

Keiko Oshida1, Takeshi Nagashima, Takuya Ueda, Hiroshi Yagata, Naoto Tanabe, Shigeharu Nakano, Takashi Nikaidou, Hiroyuki Funatsu, Hideyuki Hashimoto, Masaru Miyazaki.   

Abstract

The purpose of this study was to assess the relationship between functional parameters derived from dynamic MR imaging and the histological findings of breast ductal carcinoma in situ (DCIS) and DCIS with invasive foci, and to evaluate whether these parameters might predict DCIS patient outcome. Two parameters, amplitude A and k(21), were determined from multicompartmental pharmacokinetic analyses of dynamic MR mammography in 39 patients with needle biopsy-proven primary DCIS. After surgery, the histological tumor characteristics, including microvessel density (MVD) (anti-CD-34), vascular permeability (anti-VEGF antigen) and histological grade, were evaluated. Histology revealed 27 pure DCIS and 12 DCIS with invasive foci. In pure DCIS, positive correlations between MVD and amplitude A (r=0.56, P<0.0025) and between MVD and k(21) (r=0.43, P=0.02) were found. As for histological grade, the differences in both functional parameters of grade 1 versus grade 2 and grade 1 versus grades 2 and 3 combined were significant (P<0.05). No significance was found in the analysis of DCIS with invasive foci. Our results indicated that functional MRI-based parameters might possess the potential to predict the outcome of patients with DCIS. Further study will be needed with larger series over longer periods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15789211     DOI: 10.1007/s00330-005-2661-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  46 in total

1.  Microvessel quantitation in intraductal and early invasive breast carcinomas.

Authors:  A Santinelli; M Baccarini; P Colanzi; G Fabris
Journal:  Anal Quant Cytol Histol       Date:  2000-08       Impact factor: 0.302

2.  Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor?

Authors:  S G Orel
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

3.  Evaluation of tumor angiogenesis with contrast-enhanced dynamic magnetic resonance mammography.

Authors:  Nermin Tuncbilek; Ercument Unlu; Hakki M Karakas; Bilge Cakir; Filiz Ozyilmaz
Journal:  Breast J       Date:  2003 Sep-Oct       Impact factor: 2.431

4.  In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Authors:  P Viehweg; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.310

5.  Pathophysiologic basis of contrast enhancement in breast tumors.

Authors:  M V Knopp; E Weiss; H P Sinn; J Mattern; H Junkermann; J Radeleff; A Magener; G Brix; S Delorme; I Zuna; G van Kaick
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

6.  Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.

Authors:  S Mussurakis; D L Buckley; P J Drew; J N Fox; P J Carleton; L W Turnbull; A Horsman
Journal:  Clin Radiol       Date:  1997-07       Impact factor: 2.350

7.  Ductal carcinoma in situ: MR imaging-histopathologic correlation.

Authors:  R Gilles; B Zafrani; J M Guinebretière; M Meunier; O Lucidarme; A A Tardivon; F Rochard; D Vanel; S Neuenschwander; R Arriagada
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

8.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

9.  Intraductal carcinoma of the breast: follow-up after biopsy only.

Authors:  D L Page; W D Dupont; L W Rogers; M Landenberger
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

10.  Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination.

Authors:  M Van Goethem; K Schelfout; E Kersschot; C Colpaert; I Verslegers; I Biltjes; W A Tjalma; J Weyler; A De Schepper
Journal:  Eur Radiol       Date:  2004-03-26       Impact factor: 5.315

View more
  14 in total

1.  Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.

Authors:  E A M Hauth; H Jaeger; S Maderwald; C Stockamp; A Mühler; R Kimmig; M Forsting
Journal:  Eur Radiol       Date:  2006-07-29       Impact factor: 5.315

2.  Size assessment of breast lesions by means of a computer-aided detection (CAD) system for magnetic resonance mammography.

Authors:  G Levrini; R Sghedoni; C Mori; A Botti; R Vacondio; A Nitrosi; M Iori; F Nicoli
Journal:  Radiol Med       Date:  2011-03-19       Impact factor: 3.469

Review 3.  Image-based biomarkers in clinical practice.

Authors:  John E Bayouth; Thomas L Casavant; Michael M Graham; Milan Sonka; Manickam Muruganandham; John M Buatti
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

4.  Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.

Authors:  Ziliang Cheng; Zhuo Wu; Guangzi Shi; Zhilong Yi; Mingwei Xie; Weike Zeng; Chao Song; Chushan Zheng; Jun Shen
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

Review 5.  Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?

Authors:  Francesco Sardanelli; Franca Podo
Journal:  Eur Radiol       Date:  2006-09-29       Impact factor: 5.315

Review 6.  Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy.

Authors:  Ute Kettritz
Journal:  Eur Radiol       Date:  2007-09-27       Impact factor: 5.315

7.  Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon.

Authors:  Garima Agrawal; Min-Ying Su; Orhan Nalcioglu; Stephen A Feig; Jeon-Hor Chen
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?

Authors:  Siwa Chan; Jeon-Hor Chen; Garima Agrawal; Muqing Lin; Rita S Mehta; Philip M Carpenter; Orhan Nalcioglu; Min-Ying Su
Journal:  J Oncol       Date:  2010-09-21       Impact factor: 4.375

Review 9.  Breast MR with special focus on DW-MRI and DCE-MRI.

Authors:  G Petralia; L Bonello; F Priolo; P Summers; M Bellomi
Journal:  Cancer Imaging       Date:  2011-06-28       Impact factor: 3.909

10.  Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion.

Authors:  C Marini; C Iacconi; M Giannelli; A Cilotti; M Moretti; C Bartolozzi
Journal:  Eur Radiol       Date:  2007-03-14       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.